FDC Limited has announced the appointment of Vishal Shah as its new Chief Financial Officer (CFO), marking a significant addition to its leadership team. With over 18 years of experience in financial management, corporate governance, and strategic operations, Shah’s appointment underscores FDC’s commitment to strengthening its leadership as it continues its path toward sustainable growth and operational excellence in the pharmaceutical and healthcare sectors.
Before joining FDC Limited, Vishal Shah served as CFO at RPG Life Sciences Ltd., where he led key financial transformation initiatives, enhanced governance structures, and streamlined business operations across Finance, Legal & Secretarial, Distribution, and IT functions. His leadership at RPG Life Sciences was instrumental in improving financial efficiency and creating long-term organizational value.
Earlier in his career, Shah held senior roles at Alkem Laboratories Ltd. and Glenmark Pharmaceuticals, gaining extensive expertise across Business Finance, Treasury, Costing, and Financial Reporting. His international tenure in Switzerland and the Czech Republic—overseeing R&D Finance, Legal, and Treasury for Glenmark’s European business—helped shape his global financial perspective and strategic approach to cross-border operations.
An alumnus of the Indian Institute of Management Ahmedabad, Vishal is widely recognized for his strategic foresight, analytical rigor, and people-first leadership style. At FDC Limited, he will be responsible for driving the company’s financial strategy, governance, and performance excellence, further reinforcing its growth trajectory and enhancing its competitiveness in the global pharmaceutical industry.
His appointment is expected to bolster FDC’s focus on innovation, financial discipline, and sustainable value creation as the company continues to expand its footprint across domestic and international markets.
, marking a significant addition to its.....){kind=link}